This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John H. Bauer, MD

Arch Intern Med. 1983;143(5):927-931.

Abstract
• Fourteen hypertensive men underwent assessment of renal function and body fluid composition following short-term (three to six weeks), long-term (five to six months), and withdrawal (two weeks) of propranolol hydrochloride mono-therapy for the treatment of hypertension. Results indicate that propranolol had little effect on glomerular filtration rate (<10% decrease); changes that did occur were directly correlated with changes in effective renal plasma flow. Propranolol therapy decreased effective renal plasma flow 14% and renal blood flow 15% during long-term therapy; decreases in renal perfusion persisted following withdrawal of therapy. Propranolol therapy was neither antidiuretic nor antinatriuretic; propranolol had no effect on urine osmolality, free water clearance, sodium clearance, or fractional sodium excretion. Furthermore, propranolol therapy did not expand plasma volume, extracellular fluid volume, or total body water. Finally, propranolol therapy had no effect on the renal handling of potassium or on serum potassium concentration.

(Arch Intern Med 1983;143:927-931)

Author Affiliations
From the Medical Service, Harry S Truman Memorial Veterans Hospital and the Department of Medicine, University of Missouri Health Sciences Center, Columbia.

Footnotes
Accepted for publication Oct 18, 1982.

Reprint requests to Medical Service (111), The Harry S Truman Memorial Veterans Hospital, Columbia MO 65201 (Dr Bauer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acid-Base and Electrolyte Abnormalities Observed in Patients Receiving Cardiovascular Drugs
Miltiadous et al.
J CARDIOVASC PHARMACOL THER 2003;8:267-276.
ABSTRACT  

The regulation and measurement of plasma volume in heart failure
Kalra et al.
J Am Coll Cardiol 2002;39:1901-1908.
ABSTRACT | FULL TEXT  

Water Intoxication Following Moderate-Dose Intravenous Cyclophosphamide
Bressler and Huston
Arch Intern Med 1985;145:548-549.
ABSTRACT  

Effects of Indoramin Therapy on BP, Renal Function, and Body Fluid Composition
Bauer et al.
Arch Intern Med 1984;144:308-312.
ABSTRACT